Skip to main content
  • English
    • Nederlands
    • Français
Home
If you have been supplied with a PIN Code, you may enter it here.
  • Sign In
  • Product Summary
  • Home
  • Therapeutic areas
    • Cardiology
      • ASCVD
      • Heart Failure
      • Events
    • Dermatology
      • Urticaria
      • Events
    • Hematology
      • ITP
    • Neurology
      • Training
      • Migraine
      • Events
    • Oncology
      • Breast Cancer
      • Melanoma
    • Ophthalmology
      • Retinal diseases
    • Rheumatology
      • Spondyloarthritis (SpA)
  • Congresses
    • Cardiology
      • BSC 2023
      • ESC 2023
    • Neurology
      • CMSC 2023
      • EAN 2023
      • ECTRIMS 2023
      • ECTRIMS 2022
    • Oncology
      • ASCO 2023
      • ASCO 2022
      • ESMO BC 2023 - Berlin
      • ESMO 2022 - Paris
      • EBCC 2022
      • SABCS 2022
  • Contact
  • Autoinflammatory Diseases

Popular Search

  • improved
  • improving
  • aimovig
  • migration
  • migraine

Recent News

Mélanie Affa
Treatment
Traitement
Search
  1. Terms of use

Terms of use

 

Terms of use - Dutch version Terms of use - French version

 

×

Ask Speakers

Contact


Novartis Pharma NV/SA: + 32 (0)2 246 16 11

 

Medical questions:

Click here

 
 

In case of an adverse event:

[email protected]
Phone number 24/h:
Bel: 0800 94 368
Lux: + 32 475 319 792
 

Subscribe to Novartis

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
Sitemap
Cookie Settings
©2023 Novartis Belgium and Luxembourg
  • Terms of use
  • Privacy Policy
  • About cookies
This website is intended for health care professionals in Belgium and Luxembourg